How to manage pediatric asthma in the emergency department (ED)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pediatric Asthma in the Emergency Department

The immediate management of pediatric asthma in the ED should include high-flow oxygen via face mask, nebulized salbutamol (5 mg) or terbutaline (10 mg) via oxygen-driven nebulizer (half doses for very young children), and oral prednisolone 1-2 mg/kg (maximum 40 mg). 1

Initial Assessment and Treatment

Assessment

  • Evaluate severity based on:
    • Respiratory rate (compared to age-appropriate norms)
    • Work of breathing (retractions, accessory muscle use)
    • Oxygen saturation
    • Peak flow measurement (in children over 5 years)
    • Mental status
    • Ability to speak in complete sentences

Immediate Treatment

  1. Oxygen: High-flow oxygen via face mask to maintain O₂ saturation >92%
  2. Bronchodilators:
    • First-line: Salbutamol 5 mg (2.5 mg for children under 2 years) or terbutaline 10 mg (5 mg for children under 2 years) via oxygen-driven nebulizer 1
    • Alternative delivery method: Metered-dose inhaler (MDI) with spacer can be as effective as nebulization for mild exacerbations 2, 3
      • Give one puff every few seconds until improvement occurs (maximum 20 puffs)
      • Use face mask attachment for very young children
  3. Corticosteroids:
    • Oral prednisolone 1-2 mg/kg (maximum 40 mg) 1, 4
    • For severe exacerbations, may need to continue for up to five days

Management Algorithm Based on Severity

Mild Exacerbation

  • Albuterol via MDI with spacer (more cost-effective than nebulization) 2
  • Reassess after 10 minutes
  • If improved: Consider discharge with appropriate follow-up
  • If not improved: Escalate to moderate exacerbation protocol

Moderate to Severe Exacerbation

  • High-flow oxygen
  • Nebulized salbutamol/albuterol or MDI with spacer (multiple doses)
  • Oral prednisolone/prednisone
  • Consider adding inhaled corticosteroids at discharge 5
  • Reassess after treatment
  • If peak flow <50% of predicted or personal best after treatment, manage as severe attack 1

Life-Threatening Exacerbation

  • Immediate high-flow oxygen
  • Continuous nebulized salbutamol/albuterol
  • IV corticosteroids if unable to take oral medication
  • Consider IV magnesium sulfate
  • Call for specialist assistance (pediatric intensivist/anesthesiologist)
  • Do not attempt intubation until the most expert available doctor is present 1

Discharge Planning

  1. Medication:

    • Albuterol via MDI with spacer (overwhelming majority of children should receive this) 6
    • Oral corticosteroids to complete 3-5 day course
    • Consider new or continued inhaled corticosteroids 6, 5
  2. Education:

    • Proper inhaler technique
    • Recognition of worsening symptoms
    • Written asthma action plan
  3. Follow-up:

    • Arrange follow-up within 48 hours
    • Contact primary care provider before discharge if possible 1

Special Considerations

Very Young Children (0-2 years)

  • Diagnosis relies almost entirely on symptoms
  • Bronchodilator response may be variable but should still be tried
  • Consider alternative diagnoses (gastroesophageal reflux, cystic fibrosis, etc.) 1

Catastrophic/Brittle Asthma

  • Identify patients with history of sudden severe attacks
  • These patients may require direct admission to intensive care
  • Consider early involvement of pediatric intensivist 1

Common Pitfalls to Avoid

  1. Underutilization of spacer devices: MDI with spacer is as effective as nebulization for many patients 2, 3

  2. Delaying corticosteroid administration: Early administration improves outcomes 1

  3. Overuse of antibiotics: Only 2.6% of asthma exacerbations should require antibiotics; avoid unless clear evidence of bacterial infection 6

  4. Aminophylline use: Should no longer be used in children at home 1

  5. Inadequate discharge planning: Failure to provide comprehensive therapy (albuterol MDI, oral steroids, and inhaled corticosteroids) 6

  6. Cardiovascular effects: Monitor for potential cardiovascular effects of albuterol, especially with repeated dosing 7

  7. Hypokalemia: Repeated dosing with albuterol can cause transient hypokalemia 7

By following this structured approach to pediatric asthma management in the ED, you can optimize outcomes while minimizing risks and unnecessary treatments.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Practicing What We Teach: Increasing Inhaler Use for Mild Asthma in the Pediatric Emergency Department.

Journal for healthcare quality : official publication of the National Association for Healthcare Quality, 2022

Research

Practice patterns in asthma discharge pharmacotherapy in pediatric emergency departments: a pediatric emergency research Canada study.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.